Last update:

Immunology news

Oncology & Cancer

New research shows how Golgi stress affects T-cells' tumor-fighting ability

The Golgi apparatus modifies, sorts and packages proteins to be sent to their final destinations, whether that's within or outside of the cell. It's a core function, but little studied in the setting of cancer immunology, ...

Oncology & Cancer

Clinical trial: Monoclonal antibody may be an effective alternative to cisplatin in treatment of head and neck cancers

Head and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report. Smokers and drinkers, as well as those with HPV infections, are disproportionately affected.

Diseases, Conditions, Syndromes

New thesis on MAIT cells provides insights into immunity and COVID-19

Tobias Kammann from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is defending his thesis titled "The diversity of MAIT cells across the human body and in COVID-19," on 29 November, ...

Oncology & Cancer

Probiotic delivers immunotherapy to shrink gut tumors in mice

Immunotherapy is a promising treatment that recruits the immune system to help fight cancer, but it has had limited success in gastrointestinal cancers. Now, researchers at Washington University School of Medicine in St. ...

Oncology & Cancer

Surprising connection between COVID-19 and cancer regression

A new study led by scientists from the Northwestern Medicine Canning Thoracic Institute and published in the Journal of Clinical Investigation has revealed a connection between COVID-19 infection and cancer regression. The ...

Immunology

Developing an antibody to combat age-related muscle atrophy

We all age. And while humanity's life expectancy has increased dramatically in the modern era, we still struggle with the inevitable health issues our bodies face as we get up in the years. For example, the decrease of muscle ...

Oncology & Cancer

AI analysis of immune cells can predict breast cancer prognosis

Researchers at Karolinska Institutet have investigated how well different AI models can predict the prognosis of triple-negative breast cancer by analyzing certain immune cells inside the tumor. The study, published in the ...

Diseases, Conditions, Syndromes

How SARS-CoV-2 defeats the innate immune response

The novel coronavirus SARS-CoV-2 has an enzyme that can counteract a cell's innate defense mechanism against viruses, explaining why it is more infectious than the previous SARS and MERS-causing viruses. A Kobe University ...

Oncology & Cancer

New CAR-T cells offer on-demand control for cancer treatment

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that can be switched on to varying degrees of intensity and then switched off on demand ...

Immunology

Key receptor reveals how gut cells detect harmful invaders

The human gut is home to helpful microbes, called the microbiota, who produce molecules known as metabolites. These metabolites are being increasingly recognized for their role in supporting our health.

Immunology

Air pollution linked to having a peanut allergy during childhood

Exposure to higher levels of air pollution as a baby is linked to having a peanut allergy throughout childhood, according to a new study. And policies aimed at tackling poor air quality could potentially reduce the prevalence ...

Health

How vitamin D deficiency can lead to autoimmune diseases

As Canadians brace for "vitamin D winter"—months when the sun's angle is too low to produce the vitamin in the skin—a McGill University study explains why vitamin D deficiency early in life is associated with a higher ...

Oncology & Cancer

Biomarker may predict immunotherapy response in liver cancer

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell Medicine investigators.

Oncology & Cancer

Scientists explore new mechanisms to combat glioblastoma

Glioblastoma is the most common and aggressive type of primary brain tumor, with an average survival rate of 15 months, according to the Centers for Disease Control and Prevention. While glioblastoma can be diagnosed at any ...

Immunology

Unique immune response in lupus paves the way for new treatments

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional pathway in patients with systemic lupus erythematosus, commonly referred to as lupus, according ...

Genetics

Uncovering a way for pro-B cells to change trajectory

Development of B cells, white blood cells that make antibodies, follows a progression of stages: common lymphoid progenitors, pre-pro-B cells, pro-B cells, pre-B cells, immature B cells, and then more mature and specialized ...